Abstract
AbstractUp to 25% of breast cancer patients in Asia present with de novo metastatic disease. We examined the survival trends of Asian patients with metastatic breast cancer over fifteen years. The impact of changes in patient’s demography, tumor characteristics, tumor burden and treatment on survival trend were examined. Patients with de novo metastatic breast cancer from three hospitals in Malaysia and Singapore (N = 856) were grouped by year of diagnosis: 1996–2000, 2001–2005 and 2006–2010. Step-wise multivariable Poisson regression was used to estimate the contribution of above-mentioned factors on the survival trend. Proportions of patients presenting with metastatic breast cancer were 10% in 1996–2000, 7% in 2001–2005 and 9% in 2006–2010. Patients in 2006–2010 were significantly older, appeared to have higher disease burden and received more chemotherapy, endocrine therapy and surgery of primary tumor. The three-year relative survival in the above periods were 20·6% (95% CI: 13·9%–28·2%), 28·8% (95% CI: 23·4%–34·2%) and 33·6% (95% CI: 28·8%–38·5%), respectively. Adjustment for treatment considerably attenuated the relative excess risk of mortality in recent years, compared to other factors. Substantial improvements in survival were observed in patients with de novo metastatic breast cancer in this study.
Topics

No keywords indexed for this article. Browse by subject →

References
32
[1]
El Saghir, N. S. et al. Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives. Crit Rev Oncol Hematol. 80, 433–449 (2011). 10.1016/j.critrevonc.2011.01.010
[2]
Andre, F. et al. Breast Cancer with synchronous metastases: Trends in survival during a 14-year period. J Clin Oncol. 22, 3302–3308 (2004). 10.1200/jco.2004.08.095
[3]
Dawood, S. et al. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol. 26, 4891–4898 (2009). 10.1200/jco.2007.14.1168
[4]
Ruiterkamp, J. et al. Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands. BMC Surgery. 128, 495–503 (2011).
[5]
Pal, S. K. et al. Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer. BMC Cance. 12, 435, 10.1186/1471-2407-12-435 (2012). 10.1186/1471-2407-12-435
[6]
Chopra, R. The Indian scene. J Clin Oncol. 19, 106–111 (2001).
[7]
Yip, C. H., Taib, N. A. & Mohamed I. Epidemiology of Breast Cancer in Malaysia. Asian Pacific J Cancer Prev. 7, 369–374 (2006).
[8]
Lim, S. E. et al. Clinical observations from a breast cancer registry in Asian women. World J Surg. 31, 1387–1392 (2007). 10.1007/s00268-007-9086-3
[9]
Sant, M. et al. Breast carcinoma survival in Europe and the United States. A Population Based Study. Cancer. 100, 715–722 (2004). 10.1002/cncr.20038
[10]
Bhoo Pathy, N. et al. The impact of breast surgery on survival of women presenting with metastatic breast cancer. British J Surg 98, 1566–1572 (2011). 10.1002/bjs.7650
[11]
Saxena N., Hartman M. & Bhoo-Pathy N. et al. Breast cancer in South East Asia: comparison of presentation and outcome between a middle income and a high income country. World J Surg. 2012 36(12), 2838–2846, 10.1007/s00268-012-1746-2. 10.1007/s00268-012-1746-2
[12]
Bhoo-Pathy N., Subramaniam S. & Taib N. A. et al. Spectrum of very early breast cancer in a setting without organised screening. Br J Cancer. 2014 110(9), 2187–2194, 10.1038/bjc.2014.183. 10.1038/bjc.2014.183
[13]
Bhoo Pathy, N. et al. Breast Cancer in Asian Women: Results from the Singapore-Malaysia Hospital Based Breast Cancer Registry. Breast. 20, S75–S80 (2011). 10.1016/j.breast.2011.01.015
[14]
Henson D. E. & Ries L. A. The relative survival rate. Cancer. 76, 1687–1688 (1995). 10.1002/1097-0142(19951115)76:10<1687::aid-cncr2820761002>3.0.co;2-i
[15]
Dickman, P. W., Sloggett, A., Hills, M. & Hakulinen, T. Regression models for relative survival. Stat Med. 23, 51–64 (2004). 10.1002/sim.1597
[16]
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

J. A C Sterne, I. R White, J. B Carlin et al.

BMJ 2009 10.1136/bmj.b2393
[17]
Royston, P. Multiple imputation of missing values: further update of ice, with an emphasis on categorical variables. Stata Journal. 9, 466–477 (2009). 10.1177/1536867x0900900308
[18]
Agarwal, G. et al. Spectrum of breast cancer in Asian women. World J Surg. 31, 1031–1040 (2007). 10.1007/s00268-005-0585-9
[19]
Feinstein, A. R., Sosin, D. M. & Wells, C. K. The Will Rogers Phenomenon—Stage Migration and New Diagnostic Techniques as a Source of Misleading Statistics for Survival in Cancer. N Eng J Med. 312, 1604–1608 (1985). 10.1056/nejm198506203122504
[20]
Mahari, Z. Demographic transition in Malaysia: The changing roles of women. Available at http://www.cwsc2011.gov.in/papers/demographic_transitions/Paper_1.pdf Accessed on 14th April 2014.
[21]
Population trends 2012. Department of Statistics, Ministry of Trade and Industry, Republic of Singapore. Available at http://www.singstat.gov.sg/publications/publications_and_papers/population_and_population_structure/population2012.pdf. Accessed on 14th April 2014.
[22]
Bhoo-Pathy, N. et al. Ethnic differences in survival after breast cancer in South East Asia. PLoS One. 7, e30995, 10.1371/journal.pone (2012). 10.1371/journal.pone
[23]
Harris, E., Barry, M. & Kell, M. R. Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival. Ann Surg Oncol. 20, 2828–2834 (2013). 10.1245/s10434-013-2998-2
[24]
Badwe, R. et al. Surgical removal of primary tumor and axillary lymph nodes in women metastatic breast cancer at first presentation: A randomized controlled trial San Antonio Breast Cancer Symposium. Abstract S2-02. Presented December 11, 2013. Available at http://www.abstracts2view.com/sabcs13/view.php?nu=SABCS13L_693&terms. Accessed on 14th March 2014. 10.1158/0008-5472.sabcs13-s2-02
[25]
Soran A. et al. Early follow up of a randomized trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer; Turkish study (protocol MF07-01). San Antonio Breast Cancer Symposium. Abstract S2-03. Presented December 11, 2013. Available at http://www.abstracts2view.com/sabcs13/view.php?nu=SABCS13L_1281. Accessed on 14th March 2014. 10.1158/0008-5472.sabcs13-s2-03
[26]
Conrad, M. E., Brown, P. & Conrad, M. G. Fatalism and breast cancer in black women. Ann Intern Med. 125, 941–942 (1996). 10.7326/0003-4819-125-11-199612010-00026
[27]
Facione, N., Miaskowski, C., Dodd, M. & Paul, S. The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med. 34, 397–407 (2002). 10.1006/pmed.2001.0998
[28]
Straughan, P. T. & Seow, A. Fatalism reconceptualized: a concept to predict health screening behavior. J Gender Cult Health. 3, 85–100 (1998). 10.1023/a:1023278230797
[29]
Taib, N. A., Yip, C. H. & Ibrahim, M. et al. Breast cancer in Malaysia: are our women getting the right message? 10-year experience in a single institution in Malaysia. Asian Pacific J Cancer Prev. 8, 141–145 (2007).
[30]
Pisani, P., Parkin, D. M. & Ngelangel, C. et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 118, 149–154 (2006). 10.1002/ijc.21343
[31]
Bergenfeldt, M., Jensen, B. V. & Skjoldbye, B. et al. Liver resection and local ablation of breast cancer liver metastases—a systematic review. Eur J Surg Oncol. 37, 549–557 (2011). 10.1016/j.ejso.2011.04.013
[32]
Howlader, M., Heaton, N. & Rela, M. Resection of liver metastases from breast cancer: towards a management guideline. Int J Surg 9, 285–291 (2011). 10.1016/j.ijsu.2011.01.009
Metrics
25
Citations
32
References
Details
Published
Nov 05, 2015
Vol/Issue
5(1)
License
View
Cite This Article
Nirmala Bhoo-Pathy, Helena Marieke Verkooijen, Ern-Yu Tan, et al. (2015). Trends in presentation, management and survival of patients with de novo metastatic breast cancer in a Southeast Asian setting. Scientific Reports, 5(1). https://doi.org/10.1038/srep16252